(Repeats to change story slug. No changes to text)
BOSTON, April 6 (Reuters) - Billionaire investor William
Ackman on Wednesday said the board of embattled drug maker
Valeant Pharmaceuticals (NYSE:VRX) Inc. VRX.TO could find a new chief
executive officer in "weeks" and said the stock will become
"investable" again once the annual report is filed.
Speaking on an investor conference call Ackman said Valeant
is now on track to deliver its delayed 10-K by month end which
will likely give the company a shot in the arm because investors
will look at the company anew.